United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 22, 2026 · Filed Jun 24, 2026

On Jun 22, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$537.74 for US$5.11M under a trading plan, leaving 40,513 shares. Filed Jun 24, 2026 (Form 4).

Sold
9,500 shares
Price
US$537.74 average (US$534.09 to US$539.90)
Value
US$5.11M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common StockOption exercise6,590US$135.4247,103Direct
Jun 22, 2026Common StockOption exercise2,910US$146.0350,013Direct
Jun 22, 2026Common StockSale232US$534.0949,781Direct
Jun 22, 2026Common StockSale995US$534.9448,786Direct
Jun 22, 2026Common StockSale1,133US$536.0247,653Direct
Jun 22, 2026Common StockSale1,000US$537.1346,653Direct
Jun 22, 2026Common StockSale3,198US$538.2943,455Direct
Jun 22, 2026Common StockSale2,671US$539.1840,784Direct
Jun 22, 2026Common StockSale271US$539.9040,513Direct

Source

View original at SEC

Related